Nan Fung Group Holdings Ltd - Q1 2023 holdings

$147 Million is the total value of Nan Fung Group Holdings Ltd's 44 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .

 Value Shares↓ Weighting
SYBX ExitSYNLOGIC INC$0-68,634
-100.0%
-0.04%
EAR ExitEARGO INC$0-2,958,099
-100.0%
-1.17%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KARUNA THERAPEUTICS INC10Q3 202334.7%
HARMONY BIOSCIENCES HLDGS IN10Q3 202321.3%
XENON PHARMACEUTICALS INC10Q3 20233.1%
BOLT BIOTHERAPEUTICS INC10Q3 20235.6%
GALERA THERAPEUTICS INC10Q3 20231.9%
KALVISTA PHARMACEUTICALS INC10Q3 20231.8%
EXELIXIS INC10Q3 20231.1%
DBV TECHNOLOGIES S A10Q3 20230.6%
ALX ONCOLOGY HLDGS INC10Q3 20231.0%
ILLUMINA INC9Q3 202321.5%

View Nan Fung Group Holdings Ltd's complete holdings history.

Latest significant ownerships (13-D/G)
Nan Fung Group Holdings Ltd Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Eargo, Inc.December 16, 20222,958,0990.7%
Stealth BioTherapeutics CorpJanuary 09, 202020,240,8174.8%
New Frontier Health CorpJanuary 02, 20209,650,0007.3%

View Nan Fung Group Holdings Ltd's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
SC 13D/A2022-12-16
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-14

View Nan Fung Group Holdings Ltd's complete filings history.

Compare quarters

Export Nan Fung Group Holdings Ltd's holdings